Ostendum in a nutshell















































Ostendum is a group of companies that focuses on the commercialization of optical detection methods regarding the presence of micro-organisms, biomarkers, (bio-)molecules and (nano-)particles.

Ostendum develops and produces both the necessary hardware and software, including its own lab-
on-a-chip line. Ostendum’s technology platform classifies as nanotech as well as biotech and Ostendum claims that its detection limit is at least 100 times more sensitive than currently available competing detection methods.

Portable, fast, and extremely sensitive detection

Ostendum is currently developing a fast and highly sensitive, portable biosensor for the detection of bacteria, viruses, yeasts, biomarkers and the like. Not only is Ostendum able to detect the micro-organisms, proteins or DNA molecules, but it will also instantaneously determine their concentration in the sample.

Venture capital, awards and special projects


In addition to the risk capital from the public-private incubator fund UT International Ventures, Ostendum has obtained venture capital from two private equity funds owned by the largest health insurer in the Netherlands, Achmea.

“This investment fits seamlessly with our mission, which is to ensure good healthcare and quality of life in an affordable and sustainable manner. It paves the way for faster, better and more efficient treatment, thus preventing unnecessary healthcare costs,” says Diana Monissen, Chair of the Board of Directors of De Friesland Zorgverzekeraar, about the company’s new venture with Ostendum.”

“Ostendum is changing the healthcare landscape by enabling doctors to analyse samples bedside, in an ambulance, in their surgeries, or even while on a housecall,” explains Roelof Konterman, Member of the Board of Directors at Achmea.”

For more information see http://www.ostendum.com/xmedi3.html


2013 Frost & Sullivan Award
Frost & Sullivan grants Ostendum the 2013 Technology Innovation Leadership Award in the category European Lab-on-a-chip Nanodevices.
Continue reading (PDF, 600KB)
Frost & Sullivan press release, 18 October 2013

Frost Multimedia Wire: Best Practices Recognition, 7 January 2014 :
Frost & Sullivan applauds Ostendum's development of multiplexing, disposable chips for
the Lab-on-Chips nanodevices market

2011 Young Technology Award
Continue reading


Ostendum is an industrial partner with the University Twente’s highly regarded Research Institute for Nanotechnology, MESA+, and participates in the High Tech Factory initiative. The latter enables Ostendum to speed up its development of low costs disposable chips, and to have access to shared production facilities within state-of-the-art clean room settings.

Ostendum was awarded with a generous Nano4Vitality subsidy, which programme is financed by the Dutch Ministry of Economic Affairs and the provinces of Overijssel and Gelderland. To this end, Ostendum works together with Zwanenberg Food Group for robust testing of the Ostendum method in a food processing environment, with the Laboratorium Microbiologie Twente/Achterhoek and the Medisch Spectrum Twente (MST) to obtain further proof of concept with real patient samples.

© 2013  Ostendum R&D b.v.